Ligand validation:8CFN

NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8CFN_NAD_C_501	94%	65%	0.073	0.972	0.56	0.77	-	1	2	0	100%	1
8CFN_NAD_A_501	90%	65%	0.08	0.962	0.54	0.79	-	1	0	0	100%	1
8CFP_NAD_C_501	99%	64%	0.045	0.984	0.58	0.8	-	1	0	0	100%	1
8CFU_NAD_A_501	99%	64%	0.05	0.988	0.58	0.79	-	1	0	0	100%	1
6F3Q_NAD_C_504	99%	52%	0.053	0.989	0.8	1.04	1	2	0	0	100%	1
8CFS_NAD_C_501	99%	64%	0.05	0.982	0.57	0.8	-	1	1	0	100%	1
8CFV_NAD_C_501	99%	67%	0.055	0.986	0.55	0.73	-	1	1	0	100%	1
3CMC_NAD_R_408	100%	20%	0.016	0.998	1.63	1.74	4	9	0	0	100%	1
3EC7_NAD_A_400	100%	18%	0.025	0.995	1.8	1.74	5	8	1	0	100%	1
4URF_NAD_A_1249	100%	44%	0.034	0.995	0.96	1.2	2	4	0	0	100%	1
2C5A_NAD_B_1374	100%	23%	0.039	0.992	1.34	1.84	6	7	1	0	100%	1
1HET_NAD_A_402	100%	10%	0.043	0.994	2.25	2.1	9	8	0	0	100%	0.9068

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.